September 13, 2023 10:32 pm | Updated 10:44 pm IST - BengaluruA multicentric randomised pilot study on “low dose immunotherapy” taken up by doctors at a private cancer hospital in Bengaluru has claimed effective results on head and neck cancer patients. “This open-labelled prospective study provides an affordable cancer treatment option in the management of head and neck cancers,” claimed doctors at the HCG Cancer hospital where the study was done. As part of the pilot study, 12 cases were studied in the 54 - 76 age group. Cancer burdenHead and neck cancers pose a substantial global health issue, comprising 4.5% of total worldwide cancer cases with a mortality rate of 4.6%. Over two lakh cases of head and neck cancers are detected every year in India.

Source: The Hindu September 13, 2023 21:34 UTC